{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "marketState": "REGULAR", "regularMarketChangePercent": 1.0830314, "regularMarketPrice": 1.4, "exchange": "STO", "shortName": "Stayble Therapeutics AB", "longName": "Stayble Therapeutics AB (publ)", "messageBoardId": "finmb_405060836", "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "se_market", "esgPopulated": false, "regularMarketTime": 1684142587, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.72, "sharesOutstanding": 14228400, "bookValue": 1.104, "fiftyDayAverage": 1.7588321, "fiftyDayAverageChange": -0.35883212, "fiftyDayAverageChangePercent": -0.20401727, "twoHundredDayAverage": 3.495158, "twoHundredDayAverageChange": -2.095158, "twoHundredDayAverageChangePercent": -0.5994459, "marketCap": 19991580, "priceToBook": 1.268116, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1583740800000, "priceHint": 4, "regularMarketChange": 0.014999986, "regularMarketDayHigh": 1.4, "regularMarketDayRange": "1.35 - 1.4", "regularMarketDayLow": 1.35, "regularMarketVolume": 32335, "regularMarketPreviousClose": 1.385, "bid": 1.365, "ask": 1.4, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 1.385, "averageDailyVolume3Month": 97223, "averageDailyVolume10Day": 238743, "fiftyTwoWeekLowChange": 0.13999999, "fiftyTwoWeekLowChangePercent": 0.1111111, "fiftyTwoWeekRange": "1.26 - 5.88", "fiftyTwoWeekHighChange": -4.48, "fiftyTwoWeekHighChangePercent": -0.7619048, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 5.88, "symbol": "STABL.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Arvid Hedvalls Backe 4", "city": "Gothenburg", "zip": "411 33", "country": "Sweden", "website": "https://www.staybletherapeutics.se", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andreas  Gerward M.Sc.", "age": 34, "title": "Co-Founder & CEO", "yearBorn": 1988, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mattias  Munnich M.Sc.", "age": 43, "title": "Co-Founder & Chief Operating Officer", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Thomas  Palsson M.Sc.", "age": 70, "title": "Chief Financial Officer", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anders  Lehmann Ph.D.", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1957, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jarkko  Kalliomaki", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}